Aldeyra Therapeutics ALDX
NASDAQ ALDX
$1.52 +0.02 (+1.33%)
At close: Aug 21, 2026 · 4:00 PM EDT

Aldeyra Therapeutics (ALDX) Return on Invested Capital (2020)

Aldeyra Therapeutics' (ALDX) quarterly Return on Invested Capital came in at 0.07% in Q4 2020, up 61.61% on a QoQ basis from 0.19% in Q3 2020.

Aldeyra Therapeutics (ALDX) Return on Invested Capital (2020) Analysis & Trends

Aldeyra Therapeutics (ALDX) has 1 years of Return on Invested Capital data on file, last reported at 0.07% in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 0.04%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -0.17%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 0.00%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 0.00%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -0.35%
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Aldeyra Therapeutics 90.18 Mn 90.18 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2020 -0.07%
Sep 30, 2020 -0.19%